Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Noninvasive assessment of haemodynamics in resistant
hypertension: the role of the renal resistive index
Konstantinos Kintis
a
, Costas Tsioufis
a
, Alexandros Kasiakogias
a
, Kyriakos Dimitriadis
a
,
Dimitris Konstantinidis
a
, Eirini Andrikou
a
, Ioannis Andrikou
a
, Sotirios Patsilinakos
b
,
Dimitris Petras
c
, Demetrios Vlahakos
d
, and Dimitris Tousoulis
a
Objective: The association of resistant hypertension
(RHTN) with renal haemodynamics is unclear. Our aim was
to evaluate differences in haemodynamic characteristics of
patients with RHTN compared with patients with
controlled hypertension (HTN) at the level of the heart,
kidney and aorta.
Methods: We studied 50 patients with RHTN confirmed
by ambulatory blood pressure monitoring and 50
controlled hypertensive patients matched for age and sex.
All participants underwent renal Doppler ultrasound to
determine the renal resistive index (RRI), a complete
echocardiographic study including measurements of
diastolic function and evaluation of augmentation index.
Results: Hypertensive patients with RHTN compared with
those without RHTN had a significantly decreased E/A ratio
(by 0.12, P ¼ 0.043), an increased E/e
0
ratio (by 3.1,
P < 0.001), increased albumin-to-creatinine ratio levels (by
49 mg/g, P ¼ 0.023) and a significantly higher RRI (by
0.078, P < 0.001) but similar augmentation index values
(P ¼ 0.79). Logistic regression revealed that presence of
RHTN was the strongest predictor of an RRI more than
0.7 after controlling for other haemodynamic variables
including blood pressure levels. Receiver-operator
characteristic analysis revealed an area under the curve
for prediction of RHTN by the RRI alone of 80.3% (95%
confidence interval: 0.72–0.89, P < 0.001). An RRI cut-
point of 0.648 has a sensitivity of 78% and a specificity
of 72% for prediction of RHTN.
Conclusion: In a well treated hypertensive population,
patients with RHTN show more pronounced renal and
cardiac haemodynamic dysfunction compared with patients
with controlled HTN. A greater RRI seems to be associated
with RHTN and may help identify such patients.
Keywords: renal haemodynamics, renal resistive index,
resistant hypertension
Abbreviations: ACR, albumin-to-creatinine ratio; AIx,
augmentation index; AUC, area under the curve; BP, blood
pressure; DM, diabetes mellitus; GFR, glomerular filtration
rate; HTN, hypertension; LV, left ventricular; LVH, left
ventricular hypertrophy; MDRD, Modification of Diet in
Renal Disease; RHTN, resistant hypertension; RRI, renal
resistive index; V
max
, peak systolic velocity; V
min
, minimal
diastolic velocity
INTRODUCTION
H
ypertension (HTN), a leading independent
risk factor for morbidity and mortality worldwide,
has a well established bidirectional cause-and-
effect relationship with kidney disease based on pathophy-
siological and epidemiological data. Out of a series of
clinical and laboratory markers of kidney dysfunction, there
has been an increasing interest in studying renal haemody-
namics by means of the renal resistive index (RRI) – a
noninvasive and reproducible measure – in patients with
cardiovascular diseases including HTN. The RRI is derived
from intrarenal Doppler waveforms and seems to be a
product of complex interaction between renal and systemic
vascular haemodynamics. Although RRI has been used for
diagnostic and prognostic assessment in renal vascular
disease and chronic kidney disease including transplan-
tation [1,2] and has been a marker of renal and extrarenal
organ damage [3], a number of studies indicate that
this index actually reflects systemic haemodynamics and
depends on the aortic pulse pressure (PP) [4,5]. Research in
hypertensive patients has shown that an increased RRI is
associated with cardiovascular risk factors [6], target organ
damage [3] as well as adverse cardiovascular and renal
outcomes [7].
Despite the improvement in the pharmacological treat-
ment of HTN, a huge number of patients remains with
uncontrolled blood pressure (BP), and among them a
portion (about 5% depending on the definition) suffer from
resistant HTN (RHTN) [8]. The latter has a more complex
pathophysiology and is accompanied by more pronounced
subclinical target organ damage and a higher risk for
cardiovascular and renal events [8]. In the present study,
we investigate differences in the degree of subclinical target
Journal of Hypertension 2017, 35:578–584
a
First Cardiology Clinic, National and Kapodistrian University of Athens, Hippokration
Hospital,
b
Department of Cardiology, Konstantopoulio General Hospital,
c
Nephrology
Department, Hippokration Hospital and
d
Department of Internal Medicine, University
of Athens, Attikon University Hospital, Athens, Greece
Correspondence to Costas Tsioufis, MD, First Cardiology Clinic, University of Athens,
Hippokration Hospital, 114 Vas. Sofias Ave, 11527 Athens, Greece. Tel: +30 2 106
131 393; fax: +30 2 132 089 522; e-mail: ktsioufis@hippocratio.gr
Received 20 July 2016 Revised 2 November 2016 Accepted 5 November 2016
J Hypertens 35:578–584 Copyright ß 2017 Wolters Kluwer Health, Inc. All rights
reserved.
DOI:10.1097/HJH.0000000000001206
578 www.jhypertension.com Volume 35 Number 3 March 2017
Original Article